BioSpace News Archive

BIO President & CEO Jim Greenwood today announced the hiring of Rich Masters as BIO’s new Executive Vice President (EVP) for Public Affairs

Managed Healthcare Executive®, a multimedia platform that provides market intelligence and solutions to C-suite executives of health plans, unveiled the results of a new survey identifying the top managed care pharmacy challenges and how health care executives are solving those problems

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that Norman Schwartz, President and CEO, and Ilan Daskal, Executive Vice President and CFO, will participate in the Goldman Sachs 40th Annual Global Healthcare Conference on Tuesday, June 11

Hospice programs will serve Martin, Okeechobee and St. Lucie counties and a freestanding inpatient hospice unit in Miami-Dade County. Hiring event in Port St. Lucie scheduled for Saturday, June 8.

Advanced Instruments, LLC is pleased to announce that LA Biosystems—a leading distributor of high quality laboratory equipment within the biotechnology, life sciences, microbiology and food safety markets—is now the exclusive distributor of its portfolio of osmometers, cryoscopes, fluorometers, and Anoxomat® jar system in Belgium.

The U.S. Food and Drug Administration today approved a new indication for the previously FDA-approved drug, Zerbaxa (ceftolozane and tazobactam) for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) in patients 18 years and olde

ILJIN SNT Co., Ltd. (“ILJIN”) today announced that it has filed an information circular (the “Circular”) and letter to shareholders in connection with the upcoming Annual General Meeting of Shareholders of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH, TSX: AUP) (“Aurinia” or the “Corporation”) to be held on Wednesday, June 26, 2019.

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it closed the previously announced sale of its NAMIC® fluid management portfolio to Medline Industries, Inc. on May 31, 2019 for $167.5 million.

Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that it has received notice of an unsolicited “mini-tender offer” by TRC Capital Corporation to purchase up to 1,000,000 shares, or approximately 0.48 percent of the company’s outstanding shares of common stock as of the date of the offer

The Honourable Ginette Petitpas Taylor, Minister of Health, and the Honourable Kirsty Duncan, Minister of Science and Sport, issue a statement on the tabling of the concussions report by the Subcommittee on Sports-Related Concussions